TLR2 and breast carcinoma: Our findings indicate that PGN-stimulated TLR2 activation in highly metastatic breast cancer MDA-MB-231 cells induced extensive molecular activations involving three important transcriptional factor activities which are essential for control of cancer cell malignant properties[34], [47], [48].